Moreover, multiple studies have shown that fibrinogen-like protein 1 (FGL1), another newly discovered ligand of LAG3 independent of MHC-II52, is upregulated in lung cancer, prostate cancer, melanoma, colorectal cancer, and breast cancer52. Here, FGL1 is linked to prostate cancer.